acridone and Breast Neoplasms studies

acridone and Breast Neoplasms

acridone has been researched along with Breast Neoplasms in 2 studies

acridone : A member of the class of acridines that is 9,10-dihydroacridine substituted by an oxo group at position 9.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

Excerpt	Relevance	Reference
"The breast cancer resistance protein ABCG2 confers cellular resistance to irinotecan (CPT-11) and its active metabolite SN-38."	7.77	The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. ( Arnaud, O; Bates, SE; Boumendjel, A; Di Pietro, A; Dumontet, C; Falson, P; Gèze, A; Guitton, J; Honorat, M; Matera, EL; Payen, L; Stein, WD, 2011)
"The breast cancer resistance protein ABCG2 confers cellular resistance to irinotecan (CPT-11) and its active metabolite SN-38."	3.77	The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. ( Arnaud, O; Bates, SE; Boumendjel, A; Di Pietro, A; Dumontet, C; Falson, P; Gèze, A; Guitton, J; Honorat, M; Matera, EL; Payen, L; Stein, WD, 2011)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Kaur, M	1
Singh, P	1
Arnaud, O	1
Boumendjel, A	1
Gèze, A	1
Honorat, M	1
Matera, EL	1
Guitton, J	1
Stein, WD	1
Bates, SE	1
Falson, P	1
Dumontet, C	1
Di Pietro, A	1
Payen, L	1

Studies

Kaur, M

Singh, P

Arnaud, O

Boumendjel, A

Gèze, A

Honorat, M

Matera, EL

Guitton, J

Stein, WD

Bates, SE

Falson, P

Dumontet, C

Di Pietro, A

Payen, L

Other Studies

2 other studies available for acridone and Breast Neoplasms

Article	Year
Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer. Bioorganic & medicinal chemistry letters, 2019, 01-01, Volume: 29, Issue:1 Topics: Acridones; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Respo	2019
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:4 Topics: Acridines; Acridones; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter,	2011

Article

Year

Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.

Bioorganic & medicinal chemistry letters, 2019, 01-01, Volume: 29, Issue:1

Topics: Acridones; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Respo

2019

The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan.

European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:4

Topics: Acridines; Acridones; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter,

2011